Pyrido [2, 3-D] pyrimidin-7-one compounds as inhibitors of PI3K-alpha for the treatment of cancer

Details for Australian Patent Application No. 2008239596 (hide)

Owner EXELIXIS, INC.

Inventors Buhr, Chris A.; Wang, Longcheng

Agent A J Park

Pub. Number AU-A-2008239596

PCT Pub. Number WO2008/127712

Priority 60/911,160 11.04.07 US

Filing date 11 April 2008

Wipo publication date 23 October 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/127712 Priority application(s): WO2008/127712

22 October 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Pyrido [2,3-D] pyrimidin-7-one compounds as inhibitors of PI3K-alpha for the treatment of cancer

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008239598-Administration of carboline derivatives useful in the treatment of cancer and other diseases

2008239595-Interferons of Rhesus and Cynomolgus origin and uses thereof